SCHEMBL20070148

SCHEMBL20070148

CC(C)OC(=O)NC1(CN2CCN(C)C(C)C2)CCN(C)CC1

nearest known ligand 0.48

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
RET P07949 17/20 0.48
DRD2 P14416 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20147498 0.91 RET (0.47) RET
SCHEMBL20626704 0.84 RET (0.40) RET
SCHEMBL20070144 0.83 RET (0.48) RETDRD2
SCHEMBL20158493 0.82 RET (0.44) RETDRD2
SCHEMBL21651960 0.81 RET (0.41) RETDRD2
SCHEMBL20147970 0.79 RET (0.39) RET
SCHEMBL20205832 0.79 RET (0.39) RET
SCHEMBL21651931 0.78 RET (0.45) RETDRD2
SCHEMBL20069523 0.78 RET (0.44) RET
SCHEMBL20070147 0.78 RET (0.43) RETDRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018071454-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS ANDREWS STEVEN W (US) 2018-04-19 WO disclosed